All News
All news
-
News Pfizer refutes the findings set out in the CMA decision
Pharma giant says it complied with established competition law. -
News Catalent becomes first CDMO to join Pharmaceutical Supply Chain Initiative
Helps shape better supply chain to pharmaceutical and healthcare Industries. -
News Endo returns rights for Belbuca to BDSI and eliminates pain sales field force
Move will allow the company to focus efforts and resources more fully on its core US Branded assets. -
News Idifarma invests in automatic capsule filling capabilities
Investment enables the CDMO to provide a one-stop-shop service from lab-scale development to manufacturing of clinical batches and dossier compilation to specialised commercial manufacturing. -
News Immunotherapy combination shows promise in advanced bladder cancer
Combining nivolumab and ipilimumab could provide significant tumour reduction. -
News Lonza to divest peptides business and operations in Braine-l’Alleud, Belgium, to PolyPeptide
The deal allows Lonza to fully focus on developing its other technologies. -
News Albumedix and NYU School of Medicine to investigate targeting novel cellular pathways in oncology
Collaboration will explore the potential of novel applications of Albumedix’s albumin-based drug delivery platform, Veltis. -
News Reducing risk of contamination on the outside of vials
SP Scientific's whitepaper emphasis the importance of using external washers to remove particles from the outside of vials. -
News Drug formulation and delivery expert appointed as Catalent's Director of Global Scientific Affairs
Brings specialist knowledge of modified release technologies, polymer engineering and science, solids, liquids, semi-solids, nasal delivery, and the switch from prescription to OTC medications -
News Planning permission granted for new Shire manufacturing site in Ireland
Site will use the latest bioprocessing techniques and will employ flexible production strategies to enable it to supply both clinical- and commercial-scale products. -
News Saneca to drive R&D initiative following €1.5 million funding
The CDMO’s initiatives include laboratory research for the preparation of APIs, with a particular focus on chiral molecules and emphasis on the principles of sustainable development and ‘green chemistry’. -
News Interim data demonstrate Sandoz proposed biosimilar rituximab has equivalent efficacy to reference product
If approved, the product could provide blood cancer patients with access to potentially life-saving medicine. -
News Novel nanoscale vehicles for drug delivery
UCL pioneers the engineering of novel nanoscale drug delivery vehicles, which can be tuned to release a range of cargos. -
News FDA approves Jardiance tablets to reduce the risk of cardiovascular death in adults with T2D
The only oral T2D medicine to provide a life-saving cardiovascular benefit. -
News Novartis SEG101 significantly reduces frequency of sickle cell pain crises in Phase II study
Represents a potentially novel disease-modifying therapeutic option. -
News Haemopharm demonstrates System For Formulating And Administering Medication at the bed-side
Haemopharm, a pioneer in the manufacture of flexible bags for sterile solutions and dialysis, will demonstrate a novel system for formulating and administering medication at the bed-side. Fillchoice® room is a medical device that provides a compounding... -
News Recipharm and Laccure agree commercial collaboration
The new product, Laccure Pessary, will be manufactured, packaged and distributed globally from Recipharm’s facility in Karlskoga that specialises in the production of semi-solid products. -
News Alvogen acquires leading nasal spray device in Russia
The Dolphin brand is currently the third largest on the Russian market for nasal rinsing. -
News LGC accelerates the development of new medicines with extractables and leachables services
As regulatory pressure increases companies are saving time and money with effective extractables and leachables programmes. -
News Aptar Pharma nears completion of elastomer component capacity in North America
The added space will house state-of-the-art clean rooms and integrated best-in-class vision equipment. -
News Type 2 diabetes drugs may be a valuable resource in the treatment of Alzheimer’s disease
T2DM therapies are capable of modifying the activity of insulin in the brain. -
News Smaller companies could carve out a sizeable niche in future influenza vaccines space
New entrants, as well as smaller companies, will expand the use of cell culture-based manufacturing methods to increase their presence. -
News Takeda to take on dengue prevention
Company to invest more than 100 million euro in dengue vaccine manufacturing plant in Germany -
News Optibrium and MolPort collaborate to improve speed and cost-efficiency of drug discovery
Partnership combines MolPort’s 6.3 Million HTS Compounds with StarDrop’s data analysis and compound design capabilities. -
News The CellSeal Automated Thawing System solves a vital aspect of cell-based therapy development
Enables detailed control in thawing of cell and gene therapies. -
News FDA accepts BLA for avelumab for the treatment of metastatic MCC for Priority Review
If approved by the FDA, avelumab could be the first treatment indicated for patients with metastatic Merkel cell carcinoma. -
News Re-usable capmats offer increased chemical resistance
The silicone capmats reseal after each piercing and may be re-pierced many times without loss of function. -
News Thousands could benefit from greater use of revolutionary stroke treatment
Mechanical thrombectomy is a more effective treatment than clot-busting drugs alone for acute stroke caused by blockage of a large blood vessel by a clot. -
News Patheon to acquire state-of-the-art manufacturing site
Company gains additional API capacity and major supply agreement with Roche -
News LEVERAGE TECHNOLOGY TO OVERCOME PULMONARY DRUG DELIVERY CHALLENGES
Jean Vuillecard, Innovation & Product Manager, and Eric Dessertenne, Head of Business Development, define the limitations of traditional strategies to train, educate and track patient adherence with inhaled therapeutics and show how connectivity and ot... -
News Catalent boosts its global OTC and prescription softgel capabilities and capacity
Company acquires two state-of-the-art facilities offering integrated softgel development, manufacturing and packaging. -
News New software platform to control the cryogenic cold chain for cellular therapies
Enables standardization and audit of remote freezing and thawing. -
News Mylan agrees to produce and market generic version of BMS's Daklimza in developing countries
The license allows Mylan to develop fixed-dose combinations that offer the potential to treat all of the six major genotypes of hepatitis C virus. -
News Study confirms Sandoz biosimilar etanercept has equivalent efficacy to originator
No clinically meaningful differences between biosimilar etanercept and the originator product in safety and efficacy over 52 weeks. -
News Enamine and Pcovery extend drug discovery collaboration
Collaboration already demonstrating successful path towards discovery and development of novel anti-infective drug candidates. -
News IL-17 inhibitors will drive psoriatic arthritis market to $12.6 billion by 2025
The increase in diagnosed prevalent cases and the launches of interleukin (IL)-17 inhibitors, such as Eli Lilly’s Taltz and AstraZeneca’s Lumicef, will drive the market. -
News Indian pharma companies forecast 30% growth in 2017 at CPHI India
Domestic sales identified as chief driver behind unexpected rise in revenues. -
News Non-small cell lung cancer market to gain over $20 billion in value by 2025
It's anticipated that 65% of the total NSCLC market will go to immuno-oncology therapies. -
News European Commission approves BMS's Opdivo for Hodgkin's
Opdivo is now the first and only PD-1 inhibitor approved for a hematologic malignancy in the European Union. -
News Rephine awarded “Industry Partner of the Year” at the Global Generics and Biosimilars Awards 2016
Rephine awarded “Industry Partner of the Year” -
News Hopes dashed for new Alzheimer drug
Lilly's solanezumab fails to meet primary endpoint of Phase III study. -
News Allergan boosts its CNS pipeline with acquisition
Chase acquisition adds a new Phase III ready program for Alzheimer's disease to Allergan portfolio. -
News NICE ‘yes’ to Imnovid in the fight against the biggest blood cancer killer in the UK
Pomalidomide available to people in England immediately via the Cancer Drugs Fund. -
News Future healthcare funding sources - heaven sent?
Many companies embracing alternative funding sources, such as angel investors, as investments from VC firms continue to decrease. -
News New asthma treatments on the horizon?
Studies suggest calcilytics may represent effective future asthma therapeutics. -
News Hikma and Vectura sign agreement to develop generic salmeterol
The asthma and COPD treatment will be delivered using Vectura’s proprietary dry powder inhalation technology and device. -
News Shire to establish rare disease innovation hub in Cambridge, Mass.
The company will create a cross-disciplinary Kendall Square campus, with teams spanning research, clinical development, medical affairs, business development and other related functions. -
News FDA gives green light to Sanofi's once-daily Soliqua 100/33
The type 2 diabetes treatment for adults will be delivered using SoloStar technology. -
News Allergan receives FDA clearance for the XEN Gel Stent
The XEN Glaucoma Treatment System reduces intraocular pressure in patients with refractory glaucoma. -
News CPHI India 2016 Event
The event was a great success with an overwhelming response. -
News GSK receives FDA approval for expanded indication for FluLaval Quadrivalent
Indication now includes use in children 6 months and older. -
News Oxford Genetics receives grant to create virus packaging cell lines
Grant will be used to tackle one of the biggest bioproduction problems currently facing the industry -
News Novartis acquires Selexys Pharmaceuticals and SelG1 antibody for reduction of pain crises in SCD
Deal followed results of Phase II SUSTAIN study of SelG1 in reduction of vaso-occlusive pain crises, a major complication of SCD with limited treatment options. -
News Intarcia's NDA tackles glycemic control and poor patient adherence head on
ITCA 650 is the first investigational drug to use Intarcia's disruptive Medici Drug Delivery System to deliver chronic medicines just once or twice yearly. -
News Amgen's erenumab significantly reduces monthly migraine days in patients with episodic migraine
Second Phase III study confirms results from previous studies. -
News Boehringer Ingelheim bevacizumab biosimilar candidate demonstrates bioequivalence to Avastin
BI 695502 met all the pre-defined primary and secondary endpoints in the INVICTAN-1 study. -
News New enteric coating for solid dosage forms offers hope for patients with ulcerative colitis
The OPTICORE coating technology allows targeted drug release in the large intestine to improve local and/or systemic drug bioavailability. -
News NICE ‘yes’ for chronic myeloid leukaemia pill
For patients this could mean more are able to achieve a normal life expectancy, without compromising on their quality of life. -
News INTERSCIENCE catalog
INTERSCIENCE catalog
-
News Catalent appoints Shannon Trilli to strengthen its corporate responsibility initiatives
Will coordinate and organize the company’s existing initiatives in sustainability and maximizing social impact, and its employee-driven community programs. -
News Cancer vaccines market will soar to $7.5 billion by 2022
Therapeutic vaccines will increase the overall survival of poor-performance-status patients, and enable more rounds of treatments to be given, thus driving market growth. -
News Adherium’s Smartinhaler dramatically improves clinical outcomes and medication adherence in children with asthma
Trial results also provide a cost-saving argument for introducing Smartinhaler into routine practice. -
News PremiumCoat - the alternative coated stopper for sensitive drugs
Coating acts as an effective barrier to many of the extractables and leachables that can be released from the elastomer. -
News Shire launches Cuvitru in the US for primary immunodeficiency
Treatment provides the opportunity for fewer infusion sites and shorter infusion durations. -
News Increased diagnoses of hemophilia A and B will drive Asia-Pacific market growth to 2022
Novo Nordisk’s N9-GP and CSL-Behring’s CSL-689 are expected to be launched in the forecast period and capture significant market share. -
News Almac expands commercial capabilities to meet industry demand for paediatric formulations
The acquisition reflects growing demand for the specialist packaging solutions for powders, minitabs or granules into stickpack sachets. -
News CSL Behring presents positive results from CSL112 Phase IIb trial
CSL112 is being developed to reduce the high incidence of early recurrent cardiovascular events. -
News Biogen boosts the executive management team of its spin-off hemophilia company
The spin-off of Bioverativ is on track to be completed in early 2017. -
News Need help with selecting a flowmeter?
Titan Enterprises offers online informative and unbiased guidance document. -
News Repatha regresses atherosclerosis in patients with coronary artery disease
Nearly two-thirds of patients experienced plaque regression with Repatha on top of optimized statin therapy. -
News New report reveals the motivations and strategies behind drug innovators' decision to outsource
Two-thirds of pharmaceutical manufacturing is outsourced; preferred providers pick up largest share. -
News Cannabinoid-based product pipeline beginning to show much promise
There are 90 pipeline cannabinoid products, including two in Phase III development. -
News GSK announces positive results in fourth consecutive pivotal trial of Benlysta in SLE
Data in Japan, China and South Korea will form basis of new regulatory submissions for Benlysta. -
News AmpliPhi Biosciences announces settlement of pending lawsuit
The company’s insurance carrier will make a cash payment of $2.0 million to NRM. -
News Xellia Pharmaceuticals receives green light from FDA to commence packaging and distribution operations at Cleveland site
Company prepares to start the production of sterile anti-infective injectable products at this site during 2018. -
News Nitto Avecia announces multiple oligonucleotide expansions
Avecia's Milford site is expected to be the largest cGMP oligonucleotide facility in the world. -
News EC approves Parsabiv for the treatment of secondary hyperparathyroidism in adults on hemodialysis
First treatment advance for secondary hyperparathyroidism in more than a decade. -
News Jardiance consistently reduced the risk of cardiovascular death in adults with type 2 diabetes
Is the only oral type 2 diabetes medicine shown to reduce the risk of cardiovascular death. -
News Sanofi receives CHMP recommendation for approval of Suliqua in the EU
Treatment combines two widely used and complementary medicines into a single daily injection for people with type 2 diabetes who are struggling to keep their blood sugar levels under control. -
News BMS's Opdivo is the first immuno-oncology treatment to receive FDA approval
Treatment proven in a Phase III trial to significantly extend overall survival for patients with recurrent or metastatic squamous cell head and neck cancer. -
News Sartorius Stedim Biotech opens new bioanalytical testing laboratory in Boston
New services to enable US biopharmaceutical companies to accelerate development of biosimilars. -
News Amgen and Janssen to co-fund studies with Kyprolis and Darzalex in patients with multiple myeloma
The first study initiated as part of this agreement is a Phase III registrational trial evaluating Kyprolis in combination with Darzalex and dexamethasone compared to Kyprolis and dexamethasone alone. -
News Allergan launches first and only oral contraceptive softgel capsule
Taytulla 1 mg/20 mcg will provide women with a new and effective option. -
News Saneca Pharma secures agreement to produce enteric-coated pellets for Menarini
CDMO to invest in its facility in Hlohovec, Slovakia, to increase the scale at which it can perform wurster coating of the pellets. -
News New, rapid screening test identifies potential therapies against drug-resistant bacteria
Screening method provides a potential new approach to repurpose known drugs and compounds. -
News Mucosis initiates FiH study of SynGEM, a needle-free nasal spray RSV vaccine
Research has shown that boosting immunity in the nose and lungs may be the best way of increasing defence against RSV. -
News Schizophrenia treatment urgently requires drugs targeting negative symptoms
Currently, there is no available drug that can treat the negative symptoms of schizophrenia, according to GlobalData. -
News Increased development of highly-targeted biologics set to change composition of asthma therapeutics market
Biologics and monoclonal antibodies to become a bigger presence within the small-molecule-dominated landscape. -
News Spanish CDMO grows by more than 50% in the last 2 years
Company's focus on low-volume, niche pharmaceutical products is meeting a largely unmet need in the industry at a global level. -
News Positive results for Alkermes’ Phase III study spell good news for major depressive disorder space
GlobalData anticipates ALKS-5461 will enter the US market in early 2018. -
News Mylan and Biocon announce FDA submission for proposed biosimilar trastuzumab
Potential to be first submission of a proposed biosimilar trastuzumab in the US. -
News AdAlta licenses Alzheimer's disease-specific shark antibodies to Crossbeta Biosciences
These shark antibodies are considered to have immediate and highly disease-specific potential for the diagnosis and treatment of Alzheimer’s disease. -
News Testing of investigational inactivated Zika vaccine in humans begins
First of five planned clinical trials to test ZPIV vaccine. -
News Seward announces merger and restructuring plans to establish FermionX Ltd
Merger with sister company, C-Tech Electronics Ltd, to form a new vertically integrated manufacturing company. -
News SMC ‘yes’ to first immunotherapy combination for skin cancer patients
Allows adult patients with advanced melanoma to receive first-line treatment with the potentially life-extending combination therapy of Opdivo (nivolumab) and Yervoy (ipilimumab) on the NHS in Scotland. -
News Spinraza meets primary endpoint at interim analysis of Phase III study in later-onset SMA
Biogen is preparing for the potential launch of Spinraza in the US possibly as early as the end of 2016. -
News Study paves the way for new autoimmune disease treatments with fewer side effects
New research has raised the possibility of minimising the side effects of treatment for patients with autoimmune diseases, such as multiple sclerosis and inflammatory bowel disease. -
News Aptar Pharma and RDD Online co-organize the second edition of RDD Asia, in Goa, India
Conference welcomes pulmonary and nasal drug delivery experts from all over the world. -
News Merck invests €250 million in production value chain in China
Merck is the first multinational enterprise to dedicate a large-scale green-field investment (€170 million) to the production of pharmaceuticals on China’s Essential Drug List. -
News Atriva Therapeutics received Notice of Allowance from USPTO
Patent will cover a method of treating a subject having a viral infection caused by an influenza virus with neuraminidase inhibitors in combination with MEK inhibitors. -
News Breakthrough immunotherapy for blood cancer becomes available to UK patients
First early access scheme for breakthrough immunotherapy in blood cancer. -
News CMS establishes unique J-code for Bendeka Injection
Provides access for patients and streamlined reimbursement. -
News Mylan and Biocon announce regulatory submission for insulin glargine accepted for eeview by EMA
Filing includes analytical, functional and pre-clinical data, and results from the pharmacokinetics and confirmatory efficacy/safety global clinical trial in Type 2 diabetes patients comparing Mylan's and Biocon's Insulin glargine with Lantus. -
News Endo begins shipment of generic Seroquel XR
Four dosage strengths of quetiapine fumarate extended release tablets being distributed. -
News Key success factors to consider when implementing a global serialisation strategy
TraceLink to present on global serialisation strategies at Pharmaceutical Serialisation & Traceability 2016. -
News Positive NICE recommendation for Halaven for patients with locally advanced or metastatic breast cancer
Is the first breast cancer treatment to be recommended by NICE in nearly a decade. -
News Recipharm invests in its Italian API facility
As well as increasing output, the company is also investing in new technologies, including flow chemistry, chromatography and hydrogenation capabilities. -
News Pfizer discontinues global development of bococizumab, its investigational PCSK9 inhibitor
Bococizumab deemed unlikely to provide value to patients, physicians, or shareholders. -
News Novartis LEE011 granted FDA Priority Review for first-line treatment of HR+/HER2- advanced breast cancer
Trial showed LEE011 plus letrozole reduced the risk of progression or death by 44% over letrozole alone. -
News CPHI India launches India Pharma Week in celebration of its 10th anniversary
10 events to drive India’s rapid pharma growth predicted to reach $55bn by 2020. -
News AmpliPhi Biosciences granted Small and Medium Enterprise status by EMA
Europe to be a key market for the company's phage-based therapies to treat bacterial infections in patients with unmet medical needs. -
News Seasonal influenza vaccines market will hit $4.3 billion by 2025
Amendments to the national immunization schedules of the US and the UK, the expansion of egg-based quadrivalent seasonal influenza vaccines across Germany, Italy, France, and Spain, and the transition from egg-based to cell culture-based vaccines will ... -
News Daiichi Sankyo to commercialize two products formulated with SentryBond abuse-deterrent technology
MorphaBond is an abuse-deterrent formulation of extended release morphine using physical and chemical barriers, without the use of aversive agents or opioid antagonists. -
News Allergan successfully completes Tobira Therapeutics acquisition
Acquisition adds global rights to highly differentiated compounds to treat multi-factorial elements of NASH. -
News Lynparza trial shows significant progression-free survival benefit for women with ovarian cancer
Access for Canadian women remains in jeopardy despite mounting evidence of significant clinical benefits of Lynparza. -
News Novartis wins two prestigious Prix Galien Foundation Awards
Gleevec recognized as "Discovery of the Decade" for Best Pharmaceutical Product, Cosentyx as Best Biotechnology Product. -
News EMA validates the MAA for avelumab for the treatment of metastatic Merkel cell carcinoma
If approved, avelumab, an investigational anti-PD-L1 IgG1, could be the first treatment indicated for patients with metastatic Merkel cell carcinoma. -
News Optibrium and Collaborative Drug Discovery partner on integration of StarDrop with CDD Vault
Collaboration provides a comprehensive platform for data management, analysis and compound design in drug discovery.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance